Lexicon Pharmaceuticals, Inc.
LXRX · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$200,403 | -$177,119 | -$101,944 | -$87,758 |
| Dep. & Amort. | $534 | $554 | $427 | $292 |
| Deferred Tax | $0 | $0 | $0 | $49 |
| Stock-Based Comp. | $13,499 | $14,340 | $11,520 | $10,577 |
| Change in WC | $14,238 | $2,659 | $402 | -$10,231 |
| Other Non-Cash | -$6,648 | -$2,331 | $744 | $54 |
| Operating Cash Flow | -$178,780 | -$161,897 | -$88,851 | -$87,017 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$1,031 | -$470 | -$1,326 | -$1,221 |
| Net Acquisitions | $0 | $0 | $69,752 | -$3,331 |
| Inv. Purchases | -$338,052 | -$223,343 | -$133,949 | -$34,261 |
| Inv. Sales/Matur. | $314,400 | $173,870 | $64,197 | $37,592 |
| Other Inv. Act. | $9,305 | $0 | -$69,752 | $3,331 |
| Investing Cash Flow | -$15,378 | -$49,943 | -$71,078 | $2,110 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $49,961 | $48,868 | -$11,700 |
| Stock Issued | $0 | $138,823 | $94,205 | $37,084 |
| Stock Repurch. | -$1,730 | -$824 | -$864 | -$2,675 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $240,079 | $0 | $0 | $0 |
| Financing Cash Flow | $238,349 | $187,960 | $142,209 | $22,709 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | $44,191 | -$23,880 | -$17,720 | -$62,198 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $22,465 | $46,345 | $64,065 | $126,263 |
| End Cash | $66,656 | $22,465 | $46,345 | $64,065 |
| Free Cash Flow | -$179,811 | -$162,367 | -$90,177 | -$88,238 |